Observational studyNutrients2026
Artificial Intelligence-Based Muscle Ultrasound: A Novel Approach to Nutritional Evaluation Beyond Quantity in Neurological Patients.
Observational study in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNeurological disease may lead to malnutrition through disease-related complications, underscoring the need for accurate muscle assessment. This study aims to evaluate an AI-based tool for quantifying and characterizing muscle ultrasound images, comparing its performance with the usual techniques of muscle mass and function.
methodsThis was a prospective, open-label, longitudinal observational study of 117 adults with neurological disorders at high nutritional risk, designed to evaluate nutritional status and clinical evolution. The clinical assessment integrated anthropometry, bioelectrical impedanciometry, handgrip strength, dysphagia testing, and rectus femoris quadriceps ultrasound. Ultrasound images were evaluated through an AI-based platform to extract muscle quantity (rectus femoris muscle area (RFMA) and rectus femoris muscle thickness (RFMT) and quality biomarkers (percentage of low-echogenicity areas (Mi), interpreted as muscle; percentage of medium-echogenicity areas (FATi), interpreted as intramuscular fat). Patients were followed for two years to record mortality.
resultsThe sample included 117 adults with neurological disorders (52.1% women), with a mean age of 63.01 (16.14) years. A total of 77 patients (65.8%) had a condition with direct neuromuscular involvement. According to Global Leadership Initiative on Malnutrition (GLIM) criteria, 73 patients (62.4%) had malnutrition, while 30 patients (25.6%) had severe malnutrition. There were no differences in muscle mass parameters, but patients with neuromuscular involvement (NM) had lower values of percentage of Mi (NM: 42.44 (9.09%) vs. 47.36 (7.74)%;
conclusionsPatients with neuromuscular disorders showed a markedly lower proportion of Mi and a higher presence of FATi compared to those with non-neuromuscular conditions. Mortality was associated with greater FATi on AI-based ultrasound analysis. These findings suggest AI-enhanced imaging captures clinically relevant tissue alterations with potential prognostic value; however, given the observational data and heterogeneity of neurological conditions, these implications should be interpreted cautiously.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.